Alkem Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹3,740.15 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.80 per cent from ₹3,603.32 crore. This corresponds to a year-on-year *(YoY) growth of 10.95 per cent.
Operating Profit
Operating Profit stands at ₹766.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 100.32 per cent from ₹382.42 crore. This corresponds to a year-on-year *(YoY) growth of 3.65 per cent.
PBDT
PBDT stands at ₹871.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 65.08 per cent from ₹528.04 crore. This corresponds to a year-on-year *(YoY) growth of 1.56 per cent.
Profit Before Tax
Profit Before Tax stands at ₹771.48 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.69 per cent from ₹422.28 crore. This corresponds to a year-on-year *(YoY) growth of 0.11 per cent.
Net Profit
Net Profit stands at ₹520.98 crore, reflecting a quarter-on-quarter *(QoQ) increase of 107.47 per cent from ₹251.11 crore. This represents a 22.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Alkem Laboratories Ltd News
Alkem Laboratories Ltd Earnings
- YOY
- QOQ
Alkem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alkem Laboratories Ltd Research Reports
Alkem Laboratories Ltd Financial Reports
Alkem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alkem Lab | 1.49% | 1.36% | -2.19% | -9.82% | -4.30% | -8.92% |
| Aurobindo Pharma | 1.38% | 5.52% | 0.17% | 5.46% | 21.95% | 44.88% |
| Lupin | 0.55% | 3.03% | -0.99% | -15.45% | -14.55% | 1.17% |
| Glenmark Pharma. | -1.07% | 3.54% | -1.21% | 5.94% | -3.54% | 21.60% |
| Biocon | 0.00% | 7.73% | -5.10% | -16.78% | -2.33% | -6.68% |
| Abbott India | -1.59% | 1.47% | -4.62% | -8.16% | 0.66% | -12.00% |
| Gland Pharma | 0.99% | 8.92% | 7.79% | 20.18% | 70.45% | 57.06% |
Company Info
Company Information
Chairman/ED & CEO : Basudeo N Singh
ED / MD / Promoter : SANDEEP SINGH
Executive Director : Mritunjay Kumar Singh
Executive Director : Madhurima Singh
Executive Director : SARVESH SINGH
Executive Director : Srinivas Singh
Independent Non Exe. Director : Narendra Aneja
Independent Non Exe. Director : Sujjain Talwar
Independent Non Exe. Director : Rajeev Kher
Independent Non Exe. Director : R L Shenoy
Independent Non Exe. Director : Neela Bhattacherjee
Independent Non Exe. Director : Diwakar Gupta
President / Company Secretary / Compliance Officer : Manish Narang